Form 4 for CRL Charles River Laboratories
Accepted 2026-08-20 16:31:03 ET · period of report 2026-08-18 · accession 0001100682-26-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-20 16:31 | 2026-08-18 | CRL | Andrews Nancy C | Dir | M - OptEx | $164.30 | +573 | 2,011 | +40% | +$94.1K |
| D | 2026-08-20 16:31 | 2026-08-18 | CRL | Andrews Nancy C | Dir | S - Sale+OE | $285.24 | -573 | 1,438 | -28% | -$163.4K |
| D | 2026-08-20 16:31 | 2026-08-18 | CRL | Andrews Nancy C | Dir | M - OptEx | $0.00 | -573 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-18 | M | A | 573 | $164.30 | 2,011 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-18 | S | D | 573 | $285.24 | 1,438 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2026-08-18 | M | D | 573 | $0.00 | 0 | D | $164.30 · 2021-03-02 to 2027-03-02 | 573 Common Stock |